미국의 피부과용 영상 기기 시장 규모, 점유율, 동향 분석 보고서 : 모달리티별, 용도별, 최종 용도별, 부문별 예측(2024-2030년)

U.S. Dermatology Imaging Devices Market Growth & Trends:

The U.S. dermatology imaging devices market size is anticipated to reach USD 1933.5 million by 2030 and is projected to grow at a CAGR of 13.50% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by several key factors. The incidence of skin cancer has been rising in the U.S., driving demand for dermatology imaging devices. The Skin Cancer Foundation reports that skin cancer is the most prevalent type of cancer, with over 5 million cases diagnosed annually. While basal and squamous cell carcinoma are highly curable if detected early, melanoma, the third most common type, is responsible for most skin cancer deaths.

The popularity of noninvasive skin rejuvenation treatments, such as laser resurfacing and radiofrequency skin tightening, has surged in recent years. For instance, in October 2023, Reveal Lasers LLC introduced Denza, a revolutionary radio frequency (RF) skin-tightening device poised to transform the industry. Procedures like these use specialized imaging devices to precisely target problem areas and deliver controlled energy to the skin, stimulating collagen production and improving skin tone and texture without the need for extensive surgery.

The market has shown robust growth driven by technological advancements and increasing demand for non-invasive diagnostic tools. Over recent years, there has been a notable shift towards high-resolution imaging systems capable of providing detailed insights into skin conditions such as melanoma, psoriasis, and acne. This trend is supported by the rising incidence of skin disorders and the need for accurate early diagnosis. Dermatologists are increasingly adopting advanced imaging modalities such as dermoscopy, optical coherence tomography (OCT), and confocal microscopy, which offer enhanced visualization and aid in precise lesion characterization. Furthermore, there is a growing emphasis on integrating imaging technologies with artificial intelligence (AI) algorithms for automated analysis and decision support. Regulatory approvals for new imaging devices and expanding reimbursement coverage have also bolstered market growth. Looking forward, innovations in imaging technology and AI-driven analytics are expected to continue driving the evolution of the U.S. market, catering to the increasing demand for effective, non-invasive diagnostic solutions in dermatology practices.

U.S. Dermatology Imaging Devices Market Report Highlights:

• Based on modality, the dermatoscope segment led the market with the largest revenue share of 41.18% in 2023, due to the rising incidences of skin cancer and technological advancements
• The digital photographic imaging segment is anticipated to grow at the fastest CAGR during the forecast period. This can be attributed to the availability of smartphones for capturing high-quality skin lesion images
• Based on application, the skin cancer segment led the market with the largest revenue share of 48.63% in 2023, due to the increasing prevalence and awareness of skin cancers
• The plastic and reconstructive surgery segment is expected to grow at a significant CAGR during the forecast period, due to technological innovations
• Based on end use, the hospitals segment led the market with the largest revenue share of 43.99% in 2023. This is attributed to the increased use of advanced dermatology imaging devices in hospitals
• The dermatology centers segment is expected to grow at the significant CAGR over the forecast period, due to easier access to dermatological services

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Modality
  • 1.2.2. Application
  • 1.2.3. End use
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Volume price analysis (Model 2)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Modality outlook
  • 2.2.2. Application outlook
  • 2.2.3. End use outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Dermatology Imaging Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising incidence of skin cancer
    • 3.2.1.2. Growing prevalence of skin disorders
    • 3.2.1.3. Technological Advancements
    • 3.2.1.4. Growing demand for minimal invasive dermatology procedures
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of dermatology imaging devices
• 3.3. U.S. Dermatology Imaging Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. Dermatology Imaging Devices Market: Modality Estimates & Trend Analysis

• 4.1. Modality Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. U.S. Dermatology Imaging Devices Market by Modality Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 4.4.1. U.S. Dermatology Imaging Devices
    • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.2. Digital Photographic Imaging
    • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.3. Optical Coherence Tomography (OCT)
    • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.4. Dermatoscope
    • 4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.5. High Frequency Ultrasound
    • 4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.6. Others
    • 4.4.1.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Dermatology Imaging Devices Market: Application Estimates & Trend Analysis

• 5.1. Application Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. U.S. Dermatology Imaging Devices Market by Application Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 5.4.1. Skin Cancers
    • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Inflammatory Dermatoses
    • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2.2. Skin psoriasis
    • 5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2.3. Eczema (Atopic dermatitis)
    • 5.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2.4. Others
    • 5.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Plastic and Reconstructive Surgery
    • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. Others
    • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Dermatology Imaging Devices Market: End Use Estimates & Trend Analysis

• 6.1. End Use Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. U.S. Dermatology Imaging Devices Market by End Use Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 6.4.1. Hospitals
    • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Dermatology centers
    • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Specialty Clinics
    • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. U.S. Dermatology Imaging Devices Market: Region Estimates & Trend Analysis

• 7.1. Regional Market Share, 2023 & 2030
• 7.2. U.S. Dermatology Imaging Devices Market by Region Outlook
• 7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 7.3.1. West
    • 7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Midwest
    • 7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Northeast
    • 7.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.4. Southwest
    • 7.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.5. Southeast
    • 7.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company heat map analysis, 2023
• 8.4. Company Profiles
  • 8.4.1. Canfield Scientific, Inc.
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. FotoFinder Systems GmbH
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. e-con Systems Inc.
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Courage+Khazaka electronic GmbH
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Longport, Inc.
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Cortex Technology
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. DRAMINSKI S. A.
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. GE HealthCare
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. VisualSonics
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Clarius
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives
  • 8.4.11. Koninklijke Philips N.V.
    • 8.4.11.1. Company overview
    • 8.4.11.2. Financial performance
    • 8.4.11.3. Product benchmarking
    • 8.4.11.4. Strategic initiatives
  • 8.4.12. Michelson Diagnostics Ltd (MDL)
    • 8.4.12.1. Company overview
    • 8.4.12.2. Financial performance
    • 8.4.12.3. Product benchmarking
    • 8.4.12.4. Strategic initiatives
  • 8.4.13. Caliber Imaging and Diagnosis.
    • 8.4.13.1. Company overview
    • 8.4.13.2. Financial performance
    • 8.4.13.3. Product benchmarking
    • 8.4.13.4. Strategic initiatives
  • 8.4.14. DermLite
    • 8.4.14.1. Company overview
    • 8.4.14.2. Financial performance
    • 8.4.14.3. Product benchmarking
    • 8.4.14.4. Strategic initiatives